Check out our most popular compounded medications! Get Started
Dimercaptosuccinic Acid (DMSA) 50 mg Slow Release Capsules are a specialized compounded formulation designed to provide a controlled and prolonged release of the active ingredient. This prescription medication is primarily used in the treatment of heavy metal poisoning, lead poisoning, and Wilson's disease. DMSA is a potent chelating agent that effectively binds to heavy metals present in the body, facilitating their excretion through urine. It is also utilized in the management of certain types of kidney disease.
The unique formulation of these capsules incorporates Methocel E4M, a controlled-release polymer. This innovative technology ensures the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only enhances the efficacy of the medication but also reduces the dosing frequency, thereby improving patient compliance, particularly for those requiring a medication with a controlled and prolonged release profile.
DMSA 50 mg Slow Release Capsules are administered orally, typically once a day. It is crucial to swallow the capsules whole with a full glass of water and to adhere strictly to the dosing regimen prescribed by your healthcare provider. It is not advisable to alter the dosage without professional medical advice.
While DMSA 50 mg Slow Release Capsules are generally well-tolerated, some patients may experience side effects such as nausea, vomiting, diarrhea, and abdominal pain. If you encounter any of these or other adverse effects, it is important to contact your healthcare provider immediately.
For any queries or concerns regarding this compounded formulation, please do not hesitate to contact us at Bayview Pharmacy.
Dimercaptosuccinic Acid 50 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
These capsules may interact with other medications, supplements, or herbal products. It is crucial for patients to inform their healthcare provider of all medications, supplements, and herbal products they are taking before starting this medication. Any changes to medication dosage should only be made under the guidance of a healthcare provider.
Interactions may occur with antacids, iron supplements, and other medications that contain metals. It is recommended not to take these within 2 hours of taking Dimercaptosuccinic Acid 50 mg Slow Release Capsules. Certain antibiotics, such as penicillins, cephalosporins, and tetracyclines, as well as certain anticonvulsants like phenytoin and carbamazepine, may also interact with these capsules. The same precaution applies to certain diuretics, anticoagulants, immunosuppressants, nonsteroidal anti-inflammatory drugs (NSAIDs), and antifungals.
Dimercaptosuccinic Acid 50 mg Slow Release Capsules may be used to treat certain disease states, such as Wilson's disease, cystinuria, and lead poisoning. Patients should inform their healthcare provider of any other medical conditions they may have before taking this medication.
If you have any questions about the interactions of Dimercaptosuccinic Acid 50 mg Slow Release Capsules, please consult with your healthcare provider or pharmacist.
Dimercaptosuccinic Acid (DMSA) 50 mg Slow Release Capsules are a specialized formulation designed to treat heavy metal poisoning, lead poisoning, Wilson's Disease, and certain types of kidney disease. DMSA is a chelating agent that binds to heavy metals, aiding the body in their excretion. This formulation is encapsulated with Methocel E4M, a controlled-release polymer, which allows for a gradual release of the active ingredient over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
When taken orally, DMSA is slowly released into the body, providing a more sustained release of the medication. This slow release formulation helps to mitigate potential side effects such as nausea, vomiting, and diarrhea. DMSA 50 mg Slow Release Capsules are typically taken once daily, with or without food. Consistency in the timing of the dose is crucial to ensure a steady release of the medication.
While on DMSA, it is important to maintain adequate hydration to assist in flushing heavy metals from the body. Regular monitoring of blood levels of heavy metals and kidney function is also essential to ensure the medication's effectiveness. If you have any questions about DMSA 50 mg Slow Release Capsules, please do not hesitate to reach out for further information.
Dimercaptosuccinic Acid 50 mg Slow Release Capsules are a versatile treatment option for a variety of conditions. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules can be used to treat heavy metal poisoning, including exposure to copper, iron, and zinc. The capsules can be beneficial for patients with certain types of kidney stones, specifically cystine stones.
Dimercaptosuccinic Acid 50 mg Slow Release Capsules can also be used to manage certain types of anemia, such as sideroblastic anemia. They are also beneficial in treating certain liver diseases, including biliary cirrhosis. Furthermore, these capsules can be used to treat certain kidney diseases, such as Fanconi Syndrome.
If you have any questions about the use of Dimercaptosuccinic Acid 50 mg Slow Release Capsules for any of these conditions, please do not hesitate to reach out for more information.
The main ingredient in these capsules is Dimercaptosuccinic Acid, which is present in a concentration of 50 mg.
Methocel E4M is a type of controlled-release polymer. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
'Slow release' refers to the gradual release of the medication over time. This is achieved through the use of a controlled-release polymer, which allows the medication to be absorbed slowly by the body, providing a longer duration of action.
Due to the slow-release nature of these capsules, they are typically taken less frequently than immediate-release medications. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
Slow-release capsules offer several benefits. They provide a sustained therapeutic effect, reduce the frequency of dosing, and improve patient compliance. This is particularly beneficial for medications that require a controlled and prolonged release profile.
No, the capsules should not be opened, crushed, or chewed. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
As with any medication, there may be potential side effects. It is important to discuss these with your healthcare provider before starting the medication.
Before starting any new medication, it is important to discuss with your healthcare provider about any other drugs you are currently taking. This includes prescription medications, over-the-counter drugs, and herbal supplements.
Store the capsules at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NY, NJ, NH, FL, and ME. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
